MoneyWorks4Me

Biocon informs about press release

26 Apr 2021 Evaluate

Biocon has informed that it has attached a Company Statement on 26th April titled ‘Biocon Biologics and Viatris Receive European Commission Approval for Biosimilar Bevacizumab’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..